Success Metrics

Clinical Success Rate
76.9%

Based on 10 completed trials

Completion Rate
77%(10/13)
Active Trials
1(5%)
Results Posted
20%(2 trials)
Terminated
3(14%)

Phase Distribution

Ph not_applicable
7
33%
Ph phase_4
5
24%
Ph phase_1
3
14%
Ph phase_2
4
19%
Ph phase_3
1
5%

Phase Distribution

3

Early Stage

4

Mid Stage

6

Late Stage

Phase Distribution20 total trials
Phase 1Safety & dosage
3(15.0%)
Phase 2Efficacy & side effects
4(20.0%)
Phase 3Large-scale testing
1(5.0%)
Phase 4Post-market surveillance
5(25.0%)
N/ANon-phased studies
7(35.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

76.9%

10 of 13 finished

Non-Completion Rate

23.1%

3 ended early

Currently Active

1

trials recruiting

Total Trials

21

all time

Status Distribution
Active(2)
Completed(10)
Terminated(3)
Other(6)

Detailed Status

Completed10
unknown6
Terminated3
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
1
Success Rate
76.9%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (15.0%)
Phase 24 (20.0%)
Phase 31 (5.0%)
Phase 45 (25.0%)
N/A7 (35.0%)

Trials by Status

terminated314%
completed1048%
not_yet_recruiting15%
unknown629%
recruiting15%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT07085624Not Applicable

Early Optimization of Ceftazidime Regimen in Critical Care

Not Yet Recruiting
NCT07016165Phase 4

Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies

Recruiting
NCT02526004Not Applicable

Cystic Fibrosis Microbiome-determined Antibiotic Therapy Trial in Exacerbations: Results Stratified

Completed
NCT04319328

Is Cefazolin, Ceftazidime and Ciprofloxacin Dosing Optimal in Hemodialysis Patients?

Completed
NCT02840136Not Applicable

LC-MS/MS Based Method Development for the Monitoring of Antibiotic Concentrations in Sputum of Cystic Fibrosis Patients

Terminated
NCT02787057Not Applicable

Vancomycin Plus Moxifloxacin Versus Vancomycin Plus Ceftazidime for the Treatment of Peritoneal Dialysis (PD)-Related Peritonitis

Completed
NCT03754387Not Applicable

Antibiotic Therapy vs Laparscopic Appendectomy in Pediatric Chronic Appendicitis

Unknown
NCT03404739Phase 2

Single- Versus Multiple-dose Antimicrobial Prophylaxis for The Prevention of Infectious Complications Associated With Peroral Endoscopic Myotomy(POEM) for Achalasia

Unknown
NCT00921024Phase 2

Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract Infections

Completed
NCT03376529Phase 1

Phase 1 Study to Evaluate DDI, PK, Safety, Tolerability of SPR741

Completed
NCT01290900Phase 1

A Single-centre, Randomised, Double-blind, Placebo-controlled, Four Way Crossover Phase I Study to Investigate the Effect on QT/QTc Interval of Ceftazidime NXL104 or Ceftaroline Fosamil NXL104, Compared With Placebo, Using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male Volunteers

Completed
NCT01430910Phase 1

A Study to Assess the Levels of Two Antibiotics in the Blood When Given Together and Separately

Completed
NCT02837835Phase 3

Lung Concentrations of Ceftazidime in Patients With Ventilator-associated Pneumonia

Completed
NCT01784445Phase 4

Post ERCP Pancreatitis Prevention in Average Risk Patients

Completed
NCT01344512Not Applicable

Population Pharmacokinetics of Anti-infectious Drugs in Children

Completed
NCT01455246Phase 2

Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis

Terminated
NCT00752882Phase 2

Ceftazidime Pharmacokinetic in Cerebrospinal Fluid Between Continuous and Intermittent Administration

Unknown
NCT01044719Phase 4

Duration of Antibiotics in Infective Exacerbations of Cystic Fibrosis

Unknown
NCT00579956Not Applicable

A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe Melioidosis

Unknown
NCT00333385Phase 4

Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis

Terminated

Drug Details

Intervention Type
DRUG
Total Trials
21